Clinical Trial Update: Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial investigates intraperitoneal administration of TROP2 CAR-engineered IL-15-transduced cord blood–derived NK cells for treatment of platinum-r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesonephric-like Adenocarcinoma
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• TROP2 CAR IL-15-transduced cord blood-derived NK cells

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Cancer, Ovarian Cancer | Phase 1, Phase 2 | Status: RECRUITING